Equity Details
Price & Market Data
Price: $0.603
Daily Change: +$0.0115 / 1.91%
Daily Range: $0.59 - $0.644
Market Cap: $9,923,391
Daily Volume: 108,538
Performance Metrics
1 Week: 4.77%
1 Month: 0.69%
3 Months: -14.47%
6 Months: -79.27%
1 Year: -68.65%
YTD: -90.44%
About CalciMedica, Inc. (CALC)
A complete market overview for CalciMedica, Inc. (CALC). The stock is at 0.603, with a daily change of +$0.0115 / 1.91%. Market cap: 9,923,391. Delve into its YTD and 3-month performance.
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.